APATURA: a Phase 2a Study of Elarekibep, an Inhaled IL-4 Receptor Alpha Inhibitor, in Moderate-to-severe Asthma
EUROPEAN RESPIRATORY JOURNAL(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined